COA Coming Soon

FRAG 17-23. 10mg

$55.00

FRAG 17–23 is a synthetic, N-terminally acetylated heptapeptide corresponding to amino-acid residues 17–23 of thymosin beta‑4. This sequence is studied in laboratory models involving actin-related processes, cellular migration, endothelial responses, and tissue-repair signaling.

For laboratory research use only. Not for human or veterinary use.

Disclaimer

All products sold on this website are for laboratory research use only. They are not intended for human consumption, medical use, or cosmetic use. By purchasing, you confirm that you are a qualified researcher and understand the proper handling and storage procedures for research-grade materials. No medical claims are made or implied.

Description

Product Details

Product Overview

Unlike full-length thymosin beta‑4, FRAG 17–23 contains only the seven-amino-acid sequence associated with its actin-binding region. Researchers use this fragment to investigate peptide–actin interactions, cell motility, structure–activity relationships, and related cellular signaling pathways.

All reported findings are experimental and do not establish safety or effectiveness in humans.

Product Details

  • Product: FRAG 17–23
  • Common name: TB‑500 Fragment
  • Parent peptide: Thymosin beta‑4
  • Sequence: Ac‑LKKTETQ‑OH
  • Peptide length: 7 amino acids
  • Molecular formula: C₃₈H₆₈N₁₀O₁₄
  • Molecular weight: 889.01 g/mol
  • CAS number: 885340‑08‑9
  • Amount: 10 mg per vial
  • Form: Lyophilized research material
  • Purity and testing: Refer to the batch-specific Certificate of Analysis

Research Applications

FRAG 17–23 may be studied in controlled laboratory settings involving:

  • Actin-binding and cytoskeletal research
  • Cellular migration and motility models
  • Endothelial-cell response studies
  • Experimental tissue-repair signaling
  • Peptide structure–activity analysis

Storage and Handling

Store sealed at −20°C or colder, protected from moisture and light. Follow the storage requirements listed on the batch-specific Certificate of Analysis. Handle only with appropriate laboratory procedures and personal protective equipment.

Research-Use Notice

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE.

This product is not a drug, food, dietary supplement, or cosmetic. It is not intended to diagnose, treat, cure, or prevent any disease. No directions for human administration or dosage are provided. Purchase and handling are restricted to qualified researchers who accept responsibility for compliance with applicable laws and regulations.

Research Focus

Intended Use

This product is intended exclusively for:

  • Laboratory research
  • Analytical testing
  • In vitro experimentation
  • Preclinical investigative studies

Handling Guidelines

  • Handle using appropriate laboratory safety procedures
  • Utilize proper protective equipment (PPE) during handling
  • Reconstitute and store according to standard laboratory protocols
  • Avoid repeated freeze-thaw cycles

Storage Conditions

  • Store in a cool, dry, and dark environment
  • Refrigeration recommended for extended storage
  • Ensure vial remains tightly sealed when not in use

Quality Assurance

Each batch is subject to internal quality control procedures, which may include:

  • Purity verification
  • Identity confirmation
  • Visual inspection

Documentation such as Certificates of Analysis (COA) may be available upon request.

Compliance Notice

  • For Research Use Only
  • Not for human or veterinary use
  • Not intended to diagnose, treat, cure, or prevent any disease
  • Not a drug, food, or cosmetic product

This product is sold strictly for use by qualified professionals in controlled research settings.

Purchaser Acknowledgment

By purchasing this product, the buyer confirms that:

  • They are a qualified researcher or purchasing on behalf of one
  • They understand the nature of research-use-only materials
  • They will comply with all applicable laws and regulations regarding handling and use

HappyPeps maintains strict sourcing and handling standards to ensure consistency and reliability across all research materials.

Specification Summary

FRAG 17–23 is a synthetic, N-terminally acetylated heptapeptide corresponding to amino-acid residues 17–23 of thymosin beta‑4. This sequence is studied in laboratory models involving actin-related processes, cellular migration, endothelial responses, and tissue-repair signaling.

COAs Coming Soon.

There are no reviews yet.

Be the first to review “FRAG 17-23. 10mg”

Your email address will not be published. Required fields are marked *

Tested Quality

Each peptide batch is rigorously tested through our third-party labs.

Trusted Source

We are a USA-based company and provide priority shipping to the USA.
0